Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Vascul Pharmacol ; 80: 59-66, 2016 May.
Article in English | MEDLINE | ID: mdl-26779598

ABSTRACT

Inflammatory injury and hypoperfusion following cardiopulmonary bypass (CPB) are associated with potential brain injury in relationship between CPB, memory impairment, changes in cerebral vascular reactivity and both systemic and cerebral inflammatory reaction. The objective of this study was to assess the preventive effect of a pretreatment with simvastatin or fenofibrate on neurovascular and cognitive consequences of CPB. Male Sprague-Dawley rats were treated by control diet, simvastatin 10 mg/kg/day or fenofibrate 200 mg/kg/day for 14 days before CPB surgery and were sacrificed immediately after surgery or 24h later. Cognitive function, vascular reactivity, neuronal counts in CA1 and CA3 hippocampal regions, and inflammatory markers were assessed. CPB induced memory impairment and endothelial dysfunction 24h after surgery associated with neuronal loss. Neuronal loss was reduced by simvastatin or fenofibrate treatment in parallel to memory alteration prevention. Pretreatment by simvastatin and fenofibrate prevented CPB-induced endothelial dysfunction. CPB led to early and marked release of TNFα and overexpression of ICAM-1. Both inflammatory marker expression was decreased in the pretreated groups by lipid-lowering drugs. In a rat model of CPB, we demonstrated that simvastatin and fenofibrate protected against CPB-induced endothelial dysfunction, cerebral and systemic inflammation in parallel to memory impairment prevention.


Subject(s)
Cardiopulmonary Bypass/adverse effects , Cerebrovascular Disorders/prevention & control , Cognition Disorders/prevention & control , Hypolipidemic Agents/therapeutic use , Neuroprotective Agents/therapeutic use , Animals , Avoidance Learning/drug effects , Cerebrovascular Disorders/immunology , Cerebrovascular Disorders/metabolism , Cerebrovascular Disorders/pathology , Cognition Disorders/immunology , Cognition Disorders/metabolism , Cognition Disorders/pathology , Endothelium, Vascular/drug effects , Fenofibrate/administration & dosage , Fenofibrate/therapeutic use , Hemodynamics/drug effects , Hypolipidemic Agents/administration & dosage , Lipids/blood , Male , Maze Learning/drug effects , Neurons/drug effects , Neurons/immunology , Neurons/pathology , Neuroprotective Agents/administration & dosage , Rats, Sprague-Dawley , Simvastatin/administration & dosage , Simvastatin/therapeutic use , Tumor Necrosis Factor-alpha/blood , Vasodilation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...